Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NYSE | Common Stock
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma.
The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication.
The company markets its products through direct sales organization, as well as through distributors in the United States and internationally.
Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 1, 24 | -0.70 Decreased by -18.64% | -0.57 Decreased by -22.81% |
| Feb 21, 24 | -0.63 Decreased by -18.87% | -0.55 Decreased by -14.55% |
| Nov 1, 23 | -0.50 Decreased by -11.11% | -0.55 Increased by +9.09% |
| Aug 2, 23 | -0.55 Increased by +33.73% | -0.55 |
| May 3, 23 | -0.59 Decreased by -55.26% | -0.58 Decreased by -1.72% |
| Feb 22, 23 | -0.53 Decreased by -70.97% | -0.55 Increased by +3.64% |
| Nov 2, 22 | -0.45 Decreased by -114.29% | -0.52 Increased by +13.46% |
| Aug 3, 22 | -0.83 Decreased by -654.55% | -0.44 Decreased by -88.64% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 78.05 M Increased by +9.51% | -30.44 M Decreased by -10.40% | Decreased by -39.01% Decreased by -0.81% |
| Jun 30, 23 | 80.40 M Increased by +10.61% | -32.81 M Increased by +27.94% | Decreased by -40.81% Increased by +34.86% |
| Mar 31, 23 | 73.90 M Increased by +9.19% | -34.63 M Decreased by -743.97% | Decreased by -46.86% Decreased by -689.78% |
| Dec 31, 22 | 71.23 M Decreased by -2.75% | -31.46 M Decreased by -43.84% | Decreased by -44.17% Decreased by -47.90% |
| Sep 30, 22 | 71.27 M Decreased by -4.61% | -27.58 M Decreased by -542.63% | Decreased by -38.69% Decreased by -564.00% |
| Jun 30, 22 | 72.69 M Decreased by -6.93% | -45.54 M Decreased by -160.47% | Decreased by -62.65% Decreased by -179.85% |
| Mar 31, 22 | 67.68 M Decreased by -0.42% | 5.38 M Increased by +132.65% | Increased by +7.94% Increased by +132.79% |
| Dec 31, 21 | 73.24 M Increased by +0.01% | -21.87 M Decreased by -105.41% | Decreased by -29.86% Decreased by -105.39% |